BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 472083)

  • 1. Tranylcypromine ('Parnate') overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasma.
    Youdim MB; Aronson JK; Blau K; Green AR; Grahame-Smith DG
    Psychol Med; 1979 May; 9(2):377-82. PubMed ID: 472083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One fatal and one nonfatal intoxication with tranylcypromine. Absence of amphetamines as metabolites.
    Iwersen S; Schmoldt A
    J Anal Toxicol; 1996 Sep; 20(5):301-4. PubMed ID: 8872238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination Between Drug Abuse and Medical Therapy: Case report of a tranylcypromine overdose-related fatality.
    Akhgari M; Jokar F; Etemadi-Aleagha A; Ghasemi A
    Sultan Qaboos Univ Med J; 2017 May; 17(2):e213-e217. PubMed ID: 28690895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tranylcypromine stereoisomers on monamine oxidation in man.
    Reynolds GP; Rausch WD; Riederer P
    Br J Clin Pharmacol; 1980 May; 9(5):521-3. PubMed ID: 7397067
    [No Abstract]   [Full Text] [Related]  

  • 5. A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.
    Clarke A; Brewer F; Johnson ES; Mallard N; Hartig F; Taylor S; Corn TH
    J Neural Transm (Vienna); 2003 Nov; 110(11):1241-55. PubMed ID: 14628189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranylcypromine lowers human platelet MAO B activity but not concentration.
    Fritz RR; Malek-Ahmadi P; Rose RM; Denney RM; Abell CW
    Biol Psychiatry; 1983 Jun; 18(6):685-94. PubMed ID: 6871302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to detect amphetamine or 1-amino-3-phenylpropane in humans or rats receiving the MAO inhibitor tranylcypromine.
    Sherry RL; Rauw G; McKenna KF; Paetsch PR; Coutts RT; Baker GB
    J Affect Disord; 2000 Dec; 61(1-2):23-9. PubMed ID: 11099737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranylcypromine isomers and Parkinson's disease: new aspects of an old drug.
    Reynolds GP; Riederer P; Sandler M
    J R Soc Med; 1981 Sep; 74(9):649-52. PubMed ID: 7288807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet monoamine oxidase activity and plasma levels of non-catecholic phenylethylamines in insulin-dependent diabetic subjects.
    Mosnaim AD; Karoum F; Zeller A; Callaghan OH; Singh SP; Wolf ME
    Clin Chim Acta; 1982 Dec; 126(3):237-42. PubMed ID: 6758984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use.
    Simpson GM; Frederickson E; Palmer R; Pi E; Sloane RB; White K
    Biol Psychiatry; 1985 Jun; 20(6):684-7. PubMed ID: 3922441
    [No Abstract]   [Full Text] [Related]  

  • 11. Tranylcypromine isomers in the treatment of Parkinson's disease. Biochemical effects.
    Reynolds GP; Riederer P
    Int Pharmacopsychiatry; 1981; 16(1):30-3. PubMed ID: 7298269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GCMS analysis of tranylcypromine (Parnate) in a suspected overdose.
    Crifasi J; Long C
    Forensic Sci Int; 1997 Apr; 86(1-2):103-8. PubMed ID: 9153786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet monoamine oxidase B and plasma beta-phenylethylamine in Parkinson's disease.
    Zhou G; Miura Y; Shoji H; Yamada S; Matsuishi T
    J Neurol Neurosurg Psychiatry; 2001 Feb; 70(2):229-31. PubMed ID: 11160474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranylcypromine and inhibition of MAO activity.
    Bowden CL
    J Clin Psychopharmacol; 1984 Jun; 4(3):172-3. PubMed ID: 6736280
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of single doses of tranylcypromine on platelet MAO and amine uptake in normal subjects.
    Gentil V; Alevizos B; Lader M
    Biochem Pharmacol; 1978; 27(8):1197-201. PubMed ID: 697920
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoamine oxidase inhibitor overdose.
    Thorp M; Toombs D; Harmon B
    West J Med; 1997 Apr; 166(4):275-7. PubMed ID: 9168689
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peaked "T" waves with tranylcypromine (parnate) overdose.
    Quill TE
    Int J Psychiatry Med; 1981-1982; 11(2):155-60. PubMed ID: 7263132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas chromatographic procedure for simultaneous determination of selegiline metabolites, amphetamine, methamphetamine and demethyl-deprenyl in pig plasma.
    Szebeni G; Lengyel J; Székács G; Magyar K; Gaál J; Szatmári I
    Acta Physiol Hung; 1995; 83(2):135-41. PubMed ID: 8588500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet monoamine oxidase B activity in Parkinson's disease: a re-evaluation.
    Jarman J; Glover V; Sandler M; Turjanski N; Stern G
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):1-4. PubMed ID: 8439389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.